Ardelyx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.About ARDX
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.
ARDX Key Statistics
Stock Snapshot
Ardelyx(ARDX) stock is priced at $5.50, giving the company a market capitalization of 1.37B. It carries a P/E multiple of -23.85.
As of 2025-11-07, Ardelyx(ARDX) stock has fluctuated between $5.50 and $5.64. The current price stands at $5.50, placing the stock 0.0% above today's low and -2.5% off the high.
The Ardelyx(ARDX)'s current trading volume is 1.79K, compared to an average daily volume of 5.62M.
During the past year, Ardelyx(ARDX) stock moved between $3.21 at its lowest and $6.78 at its peak.
During the past year, Ardelyx(ARDX) stock moved between $3.21 at its lowest and $6.78 at its peak.
ARDX News
Ardelyx recently reported strong third quarter financial results, raised its full-year 2025 guidance for IBSRELA revenue to between US$270 million and US$275 mi...
Ardelyx (ARDX) delivered a quarter that surprised many, with stronger-than-expected results driven by meaningful growth in its IBSRELA and XPHOZAH product lines...
Piper Sandler raised the firm’s price target on Ardelyx (ARDX) to $10 from $9 and keeps a Neutral rating on the shares. Total revenue nicely beat consensus by o...
Analyst ratings
92%
of 12 ratingsMore ARDX News
...
The investors in Ardelyx, Inc.'s ( ) will be rubbing their hands together with glee today, after the share price leapt 20% to US$6.06 in the week following its...
Ardelyx (ARDX) remains unprofitable but has managed to shrink its losses by 20% annually over the past five years, with the company now on track to achieve prof...
Ardelyx Inc ((ARDX)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Pre...